Cysteine pathways help T cells choose between multiplying and attacking tumors

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
News-Medical.Net

How the nutrient cysteine controls cancer-fighting power of T cells

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
EurekAlert!

T cell-based cancer immunotherapy: Opportunities and challenges

CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
ascopubs.org

T-cell effector cytokine signature as predictor of survival and toxicity in metastatic NSCLC patients treated with immunotherapy.

Circulating CD28-KLRG1+CD8+ T cells as prognostic indicators in advanced NSCLC chemoimmunotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...
Morning Overview on MSN

Researchers map real-time signals that trigger T cell activation

A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...